Status: Not yet recruiting
Comparison of Myval THV Series With Guideline-Directed Medical Therapy in Participants With Moderate Aortic Stenosis
The primary objective of this trial is to evaluate the safety and effectiveness of Meril's Myval THV series in comparison to Guideline-Directed Medical Therapy in participants with moderate aortic stenosis. The trial includes a total of 778 participants (389:389) from approximately 50 investigator sites globally.
Participants needed: 778
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Meril Life Sciences Pvt. Ltd.Updated: May 6, 2026
Eligibility criteria
Participants with ≥ 65 years of age. [+11]
Participants with moderate aortic stenosis undergoing concomitant CABG or surgic... [+14]